Fiber-optic navigation for TIPS liver procedure pilot
Part of Digestive system clinical trials.
This pilot study is testing a new way to guide a TIPS procedure using a special fiber-optic navigation system, which may make the shunt placement more precise for patients with serious liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You need a TIPS procedure (a stent placed in the liver to improve blood flow) for complications like fluid buildup or severe bleeding.
- You are not pregnant or breastfeeding.
- You do not have severe heart failure or an active, uncontrolled infection.
- You are not already enrolled in another study that could interfere with this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method using electromagnetic positioning to help guide ultrasound during a TIPS procedure, which creates a connection between two blood vessels in the liver to reduce pressure. It may help people with various liver-related conditions who need this procedure.
This trial compares patients who have a rare liver condition (porto-sinusoidal vascular disease) with those who have cirrhosis, to see how a procedure called TIPS (a shunt placed in the liver to reduce blood pressure) works for complications like bleeding, fluid buildup, or blood clots.
This trial tests a special stent to treat high blood pressure in the liver caused by cirrhosis. It may help patients who need a procedure called TIPS to improve blood flow.
This study tests whether placing a small tube (called a TIPS) early in the liver can help people with cirrhosis who have their first episode of moderate to severe belly fluid buildup. The goal is to see if this early procedure improves outcomes compared to standard care.
This study tests a TIPS stent graft (a tiny mesh tube placed in the liver to relieve pressure) for people with cirrhosis and complications like bleeding or fluid buildup. It aims to see how well it works and if it's safe.
This trial tests a new type of stent placed inside the liver to lower high blood pressure in the portal vein (a major vein that carries blood to the liver). It is aimed at people with cirrhosis who have serious complications like bleeding in the esophagus or stomach, or fluid buildup in the belly that does not go away. The study will see how safe and effective this stent is.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.